Wellfully 過去の業績
過去 基準チェック /06
Wellfully's earnings have been declining at an average annual rate of -37.1%, while the Pharmaceuticals industry saw earnings growing at 35.6% annually. Revenues have been declining at an average rate of 4.5% per year.
主要情報
-37.1%
収益成長率
-15.0%
EPS成長率
Pharmaceuticals 業界の成長 | 31.2% |
収益成長率 | -4.5% |
株主資本利益率 | n/a |
ネット・マージン | -469.0% |
前回の決算情報 | 31 Dec 2022 |
最近の業績更新
Recent updates
収支内訳
Wellfully の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Dec 22 | 2 | -8 | 7 | 0 |
30 Sep 22 | 2 | -8 | 7 | 0 |
30 Jun 22 | 3 | -7 | 7 | 0 |
31 Mar 22 | 2 | -7 | 7 | 0 |
31 Dec 21 | 1 | -7 | 7 | 0 |
30 Sep 21 | 1 | -7 | 6 | 0 |
30 Jun 21 | 1 | -6 | 6 | 0 |
31 Mar 21 | 1 | -6 | 5 | 0 |
31 Dec 20 | 1 | -6 | 5 | 0 |
30 Sep 20 | 1 | -5 | 5 | 0 |
30 Jun 20 | 1 | -4 | 4 | 0 |
31 Mar 20 | 2 | -3 | 4 | 0 |
31 Dec 19 | 3 | -2 | 4 | 0 |
30 Sep 19 | 3 | -2 | 4 | 0 |
30 Jun 19 | 3 | -2 | 4 | 0 |
31 Mar 19 | 2 | -2 | 3 | 0 |
31 Dec 18 | 2 | -2 | 3 | 0 |
30 Sep 18 | 2 | -2 | 3 | 0 |
30 Jun 18 | 2 | -2 | 3 | 0 |
31 Mar 18 | 2 | -1 | 3 | 0 |
31 Dec 17 | 2 | -1 | 2 | 0 |
30 Sep 17 | 2 | -2 | 3 | 0 |
30 Jun 17 | 2 | -3 | 4 | 0 |
31 Mar 17 | 2 | -4 | 5 | 0 |
31 Dec 16 | 2 | -5 | 5 | 0 |
30 Sep 16 | 2 | -4 | 5 | 0 |
30 Jun 16 | 2 | -4 | 4 | 0 |
31 Mar 16 | 2 | -3 | 4 | 0 |
31 Dec 15 | 2 | -3 | 3 | 0 |
30 Sep 15 | 2 | -3 | 3 | 0 |
30 Jun 15 | 2 | -2 | 3 | 0 |
31 Mar 15 | 1 | -2 | 3 | 0 |
31 Dec 14 | 1 | -2 | 3 | 0 |
30 Sep 14 | 1 | -2 | 3 | 0 |
30 Jun 14 | 1 | -2 | 3 | 0 |
31 Mar 14 | 1 | -2 | 2 | 0 |
31 Dec 13 | 1 | -1 | 2 | 0 |
30 Sep 13 | 1 | -1 | 2 | 0 |
30 Jun 13 | 1 | -1 | 2 | 0 |
31 Mar 13 | 1 | -2 | 2 | 0 |
31 Dec 12 | 0 | -2 | 2 | 0 |
質の高い収益: WFL is currently unprofitable.
利益率の向上: WFL is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: WFL is unprofitable, and losses have increased over the past 5 years at a rate of 37.1% per year.
成長の加速: Unable to compare WFL's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: WFL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.2%).
株主資本利益率
高いROE: WFL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.